Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-018829

CBO & EVP sold 10,281 shares at $67.01 ($688,930)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kassberg Thomas Richard CBO & EVP 2022-03-11 Sale −10,281 $67.01 $688,930 227,559 D: show line 1 in the form
Open-market sales · 10,281 sh · avg $67.01 · $688,930
Loading xslF345X03/doc4.xml…